Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. Form 144 discloses a proposed sale of 20,470 shares of common stock, to be brokered through E-TRADE on 09/11/2025, with an aggregate market value of $900,680.00. The filing shows these shares were acquired on 09/10/2025 upon vesting of restricted stock units and were granted as equity compensation by the issuer. The filing also reports a prior sale by Niccolo de Masi of 2,597,500 shares on 06/11/2025, yielding gross proceeds of $104,793,280.25. The filer certifies no undisclosed material adverse information and includes the standard attestation regarding criminal penalties for misstatement.
Form 144 notice for IonQ, Inc. (IONQ): The filing reports a proposed sale of 5,120 shares of common stock, acquired on 09/10/2025 upon vesting of restricted stock units. The shares have an aggregate market value of $225,280 and the sale is scheduled approximately for 09/11/2025 through E-TRADE Financial Corporation on the NYSE. The issuer outstanding share count shown is 297,682,418. The filer states there were no securities sold in the past three months for the account and affirms no undisclosed material adverse information is known. The document provides transaction timing, acquisition method (RSU vesting), broker, and market value but does not identify the selling person by name in the provided text.
Form 144 filed for IonQ, Inc. (IONQ) reports a proposed sale of 25,370 shares of common stock through E-TRADE with an aggregate market value of $1,116,280 and an approximate sale date of 09/11/2025. The shares were acquired on 09/10/2025 upon vesting of restricted stock units and payment was made as equity compensation on the same date. The filer discloses recent insider sales: 45,000 shares on 07/07/2025 for $2,078,100, 65,000 shares on 06/13/2025 for $2,506,757.50, and 19,976 shares on 06/11/2025 for $830,909.71. The notice includes the standard signature representation that the seller is unaware of undisclosed material adverse information.
Insider award disclosure: This Form 4 reports that Inder M. Singh, identified as CFO and COO of IonQ, Inc. (IONQ), was granted 160,294 restricted stock units (RSUs) on 09/04/2025 at no cash price recorded ($0). After the award, the reporting person beneficially owned 165,807 shares of IonQ common stock. The RSUs vest over four years: 25% on September 10, 2026 and then quarterly on December 10, March 10, June 10 and September 10 thereafter, subject to continued service.
The filing was signed by an attorney-in-fact on 09/08/2025. The Form 4 shows a non-derivative acquisition via an equity award and discloses the vesting schedule but does not report any exercised options, cash purchases, or sales.
IonQ CFO Thomas G. Kramer reported the sale of 64,578 shares of IonQ common stock on 09/03/2025 under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. The shares were sold at a weighted average price of $41.8232, with individual sale prices ranging from $40.59 to $42.98, and the reporting person retains beneficial ownership of 473,302 shares directly plus 5 shares indirectly through a child. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
IonQ, Inc. reported an executive transition, appointing Lead Independent Director Inder M. Singh as Chief Financial Officer and Chief Operating Officer effective September 4, 2025, succeeding CFO Thomas Kramer. In connection with his new roles, Mr. Singh has stepped down from the board.
Under his offer letter, Mr. Singh will receive a $500,000 annual base salary and is eligible for an annual cash bonus targeted at 100% of salary, with a prorated 2025 bonus based on the transition date. He will be granted initial equity awards consisting of RSUs valued at $6,750,000, performance-based RSUs with a target value of $18,000,000 (with an opportunity to vest in up to 200% of that target) over a three-year performance period covering calendar years 2025–2027, and an additional make-whole RSU award equal to forfeited contingent compensation, vesting on the second anniversary of the transition date.
Mr. Singh will be eligible for severance benefits under IonQ’s Amended and Restated Executive Severance Plan in the event of a covered termination, including continued salary and target bonus for 9–12 months depending on whether a change in control is involved, a pro-rata target bonus for the year of termination, COBRA subsidies aligned with the severance period, and acceleration of certain equity awards. A press release announcing the transition is filed as an exhibit.
Form 144 notice reports a proposed sale of 158,330 shares of common stock of the issuer through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $6,806,606.70. The shares were acquired on 02/24/2021 via previously exercised stock options and payment was recorded the same day. The filing lists prior sales by the same account in the past three months totaling 406,630 shares for $16,759,629.40. The notice includes the standard Rule 144 representation and references reliance on 10b5-1 sales in several prior transactions.
IonQ director William J. Teuber Jr. was granted 4,413 restricted stock units (RSUs) on 08/26/2025 as compensation. The RSUs carry a $0 grant price and will vest in full on the earlier of the 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, provided he continues to serve on the board through the vesting date. The Form 4 reports the transaction as a direct beneficial ownership change and is filed for one reporting person.
IonQ director Jim Frankola received a grant of 4,413 restricted stock units (RSUs) on 08/26/2025. The RSUs were reported on a Form 4 and are scheduled to vest in full on the earlier of the company’s 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, but only if he remains a board member through the vesting date. The grant was reported as a zero-price award, consistent with typical director compensation in the form of equity awards. The Form 4 was executed by an attorney-in-fact on 08/28/2025.
IonQ, Inc. (IONQ) filed an initial Form 3 reporting that William J. Teuber Jr., listed as a director, does not beneficially own any securities of the issuer as of the event date 08/26/2025. The filing was signed by an attorney-in-fact on 08/28/2025 and includes an Exhibit 24 power of attorney. The document confirms this is an individual filing and no non-derivative or derivative holdings are reported.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
